The systemic inflammation state in NAFLD patients could further enhance the presence of atherogenic dyslipidemia (an increase in LDL-c, TG, and apolipoprotein B and decrease in HDL) and increased carotid intima-media thickness, resulting in more CVE in these individuals [1, 5, 11]. Here, APOB is linked to metabolic dysfunction-associated steatotic liver disease.